Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2289036
Max Phase: Preclinical
Molecular Formula: C15H9BrClN3OS
Molecular Weight: 394.68
Molecule Type: Small molecule
Associated Items:
ID: ALA2289036
Max Phase: Preclinical
Molecular Formula: C15H9BrClN3OS
Molecular Weight: 394.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1nnc(-c2ccc(Cl)cc2)s1)c1ccccc1Br
Standard InChI: InChI=1S/C15H9BrClN3OS/c16-12-4-2-1-3-11(12)13(21)18-15-20-19-14(22-15)9-5-7-10(17)8-6-9/h1-8H,(H,18,20,21)
Standard InChI Key: GCQRSLZMHOJBGK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 394.68 | Molecular Weight (Monoisotopic): 392.9338 | AlogP: 4.87 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.41 | CX Basic pKa: | CX LogP: 4.92 | CX LogD: 4.88 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -2.30 |
1. NAKAGAWA Y, NISHIMURA K, IZUMI K, KINOSHITA K, KIMURA T, KURIHARA N, FUJITA T. (1996) Quantitative Structure-Activity Relationships of Larvicidal N-[5-(Substituted phenyl)-1, 3, 4-thiadiazol-2-yl]-benzamides in the Inhibition of N-Acetylglucosamine Incorporation into a Cultured Integument System, 21 (2): [10.1584/jpestics.21.195] |
Source(1):